Orthopedics

Your Article Summary

See Latest Articles

Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass
Bone , 03/21/07

Robert R. Recker, et al. - In summary, as this trial was terminated early, there was insufficient power to compare the fracture risks between alendronate and raloxifene. Safety profiles were as expected from clinical trial and post-marketing reports

Today in Bone Metabolism...keeping you current

Receive free subspecialty "5-minute updates" via email

Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/09/09

Bisphosphonate therapy: When not to monitor BMD
The Journal of Family Practice, 11/02/09

Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
Journal of Clinical Endocrinology and Metabolism, 11/10/09

See All of Bone Metabolism

Today in Clinical Pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

Bisphosphonate therapy: When not to monitor BMD
The Journal of Family Practice, 11/02/09

Osteoarthritis: A review of treatment options
Geriatrics, 10/21/09

Doxycycline for osteoarthritis of the knee or hip
Cochrane Reviews, 10/23/09

See All of Clinical Pharmacology

Today in Trauma...keeping you current

Receive free subspecialty "5-minute updates" via email

Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density
Bone , 11/20/09

Peak bone mineral density, lean body mass and fractures
Bone , 11/03/09

Hip fractures and heart failure: findings from the Cardiovascular Health Study
European Heart Journal, 11/18/09

See All of Trauma